AI Widens Search Spaces and Promises More Hits in Drug Discovery
AI platforms are enhancing discovery efforts across modalities—small-molecule drugs, RNA-based therapeutics, and protein-based therapeutics.
Stay updated with breaking news from Amit Deshwar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AI platforms are enhancing discovery efforts across modalities—small-molecule drugs, RNA-based therapeutics, and protein-based therapeutics.
Posted April 9th, 2021 for Broad Institute Welcome to the April 9, 2021 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators. Enhancing V2F maps GWASs have yielded thousands of genetic variants linked to disease. To help figure out the function of many of these variants, Joseph Nasser (now at Caltech), Drew Bergman, Charles Fulco (now at Bristol Myers Squibb), Philine Guckelberger (now at the Free University of Berlin), Benjamin Doughty (now at Stanford University), Eric Lander (on leav...